Study of Biomarker Profiles in Asia Pacific erb2+/HER2 Breast Cancer Patients Treated With Lapatinib

Clinical trial NCT01248897 · COMPLETED

Trial details

NCT number: NCT01248897
Sponsor: GlaxoSmithKline
Status: COMPLETED
Study type: OBSERVATIONAL

Neoplasms, Metastasis

Start date: 2010-08-17
Primary completion: 2013-12-01
Enrollment: 158

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.